Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients.

导出 OA

翻译打印收藏纠错

第一作者： Tong-Yoon,Kim

第一单位： Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

作者： Tong-Yoon,Kim ^[1] ; Daehun,Kwag ^[2] ; Jong-Hyuk,Lee ^[1] ; Joonyeop,Lee ^[1] ; Gi-June,Min ^[1] ; Sung-Soo,Park ^[1] ; Silvia,Park ^[3] ; Young-Woo,Jeon ^[1] ; Jae-Ho,Yoon ^[3] ; Seung-Hawn,Shin ^[1] ; Seung-Ah,Yahng ^[3] ; Byung-Sik,Cho ^[2] ; Ki-Seong,Eom ^[1] ; Yoo-Jin,Kim ^[3] ; Seok,Lee ^[4] ; Hee-Je,Kim ^[5] ; Chang-Ki,Min ^[1] ; Seok-Goo,Cho ^[3] ; Jong-Wook,Lee ^[1] ; Jong-Mi,Lee ^[3] ; Myungshin,Kim ^[1] ; Sung-Eun,Lee ^[3]

作者单位： Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[1] Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[2] Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[3] Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[4] Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[5] Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[6]

关键词 genetic alteration overt primary myelofibrosis prefibrotic primary myelofibrosis secondary myelofibrosis

DOI 10.3390/cancers14184485

PMID 36139644

发布时间 2022-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交